pmc.ncbi.nlm.nih.gov

Treatment of candidal urinary tract infection with nifuratel

Abstract

Three patients with candidal urinary tract infections were successfully treated with oral nifuratel, a nitrofuran antimicrobial agent active against yeast and Trichomonas as well as urinary bacterial pathogens. The recommended dose is 400 mg thrice daily for a week. No side effects that could be attributed to the treatment were noted. Minimum ibhibitory concentration determinations for nifuratel against Candida strains of five species showed that 48 out of 59 organisms were inhibited by 50 mg/1 or less, the three strains of Candida species eliminated from our treated patients having MICs of nifuratel in the range of 10-50 mg/1.

908

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. McGeachie J., Robinson G., Black D. Antibacterial activity of nifuratel in urine and serum. J Clin Pathol. 1972 May;25(5):447–449. doi: 10.1136/jcp.25.5.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Schönebeck J., Polak A., Fernex M., Scholer H. J. Pharmacokinetic studies on the oral antimycotic agent 5-fluorocytosine in individuals with normal and impaired kidney function. Chemotherapy. 1973;18(6):321–336. doi: 10.1159/000221279. [DOI] [PubMed] [Google Scholar]
  3. Speller D. C., Davies M. G. Sensitivity of yeasts to 5-fluorocytosine. J Med Microbiol. 1973 Aug;6(3):315–321. doi: 10.1099/00222615-6-3-315. [DOI] [PubMed] [Google Scholar]
  4. Speller D. C. Yeasts in the urine. J Antimicrob Chemother. 1975 Sep;1(3):253–254. doi: 10.1093/jac/1.3.253. [DOI] [PubMed] [Google Scholar]
  5. Tynan A. P., Macis F. R., Ward-McQuaid J. N. Nifuratel in urinary infections. Br J Urol. 1969 Jun;41(3):271–279. doi: 10.1111/j.1464-410x.1969.tb11883.x. [DOI] [PubMed] [Google Scholar]